Humira Replaces Enbrel as the Therapy Perceived by Dermatologists to be the Most Efficacious for the Treatment of …

Humira Replaces Enbrel as the Therapy Perceived by Dermatologists to be the Most Efficacious for the Treatment of …
WALTHAM, Mass., March 23 /PRNewswire/ — Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed dermatologists view Abbott/Eisai’s Humira as the most efficacious therapy for the treatment of moderate to severe psoriasis.

Read more on redOrbit

PRA International Experts Chair and Present at Late Phase Conference

PRA International Experts Chair and Present at Late Phase Conference
RALEIGH, N.C., March 25 /PRNewswire/ — PRA International, a leading Clinical Research Organization, announces that two of its Late Phase Services (LPS) experts made presentations during the annual Late Phase Drug Development World Americas (LPDDW) conference, which is taking place through 26 March 2010 in Princeton, New Jersey.

Read more on redOrbit

A Medical Revolution Leads to New Medicines

A Medical Revolution Leads to New Medicines
WASHINGTON, March 26 /PRNewswire-USNewswire/ — As recently stated in the Glenville Democrat, innovative biotechnology is leading to a greater understanding of complex diseases and better tools for diagnosing and treating conditions such as heart disease, cancer and diabetes. “The biotechnology revolution is helping create medicines that use unprecedented technologies, such as nano-sized …

Read more on redOrbit